Clinical Trials Sponsored by German Breast Group
Total 498 results
-
German Breast GroupGerman Adjuvant Breast Cancer GroupCompleted
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
German Breast GroupCompleted
-
German Breast GroupCompleted
-
German Breast GroupRecruiting
-
German Breast GroupCompleted
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
German Breast GroupCompleted
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
German Breast GroupTerminated
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
German Breast GroupCompletedBreast CancerGermany
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
German Breast GroupNovartisUnknown
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
German Breast GroupBayerCompleted
-
German Breast GroupAGO Study GroupCompleted
-
German Breast GroupAGO Study GroupCompleted
-
German Breast GroupCelgene; AmgenCompleted
-
German Breast GroupGoethe UniversityRecruiting
-
German Breast GroupBoehringer IngelheimCompleted
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly Stage Breast CancerGermany
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly-Stage Breast CarcinomaGermany, Switzerland
-
German Breast GroupHoffmann-La RocheCompleted
-
AstraZenecaGerman Adjuvant Breast Cancer GroupCompleted
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; German Breast GroupCompletedBreast CancerSpain, Germany
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
German Breast GroupHoffmann-La RocheCompleted
-
German Breast GroupNovartis Pharmaceuticals; Austrian Breast & Colorectal Cancer Study GroupCompletedBreast CancerGermany, Austria
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Karolinska University HospitalGerman Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...UnknownBreast CancerSweden, Germany, Austria
-
University of RostockGerman Breast Group; German Cancer AidActive, not recruitingBreast CancerAustria, Germany
-
German Breast GroupCompleted
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
German Breast GroupHoffmann-La Roche; AstraZenecaCompleted
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupBristol-Myers Squibb; Pharmacia; AmgenCompleted
-
Martin-Luther-Universität Halle-WittenbergGerman Breast GroupUnknown
-
West German Study GroupAGO GermanyCompletedBreast CancerGermany
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Lund University HospitalDanish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast NeoplasmsDenmark, Sweden
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany